AVITA (RCEL) CFO David D. O'Toole Buys 2,000 Shares

What Happened David D. O'Toole, Chief Financial Officer of AVITA Medical, purchased 2,000 shares on June 12, 2026, at $3.97 per share, for a total of $7,940. The transaction was an open-market purchase (transaction code P) and the Form 4 was later amended to correct the transaction code.

Key Details

• Transaction date and price: 2026-06-12, 2,000 shares at $3.97 each (total $7,940).
• Filing status: Amended Form 4 filed 2026-08-24 to correct the original transaction code (original Form 4 filed June 12 had mistakenly used code 'A').
• Shares owned after transaction: The filing notes ownership figures include unvested RSUs (footnote) but does not specify the post-transaction total in the summary provided here.
• Footnotes: F1 corrects transaction code from 'A' to 'P'; F2 notes ownership totals include unvested restricted stock units.

Context This was a straightforward open-market purchase by the company’s CFO for a modest dollar amount. Purchases by insiders can be informative, but this transaction ($7.9k) is relatively small and should be weighed alongside other insider activity and company fundamentals. The amendment corrected a reporting code rather than adding a new trade; the original report was filed the same day as the trade.